Roche’s Virtual AAN Investor Event
Roche has hosted a virtual event on Wednesday, 22 April 2026
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Fenebrutinib development overview | Alexandra Goodyear, Lifecycle Leader Fenebrutinib |
| Ph III (FENhance 1/2) fenebrutinib vs. Aubagio in RMS | Jiwon Oh, MD, PhD, FRCPC, Medical Director, Barlo Multiple Sclerosis Program, Associate Professor, Division of Neurology, St. Michael’s Hospital, University of Toronto, Staff Neurologist, St. Michael’s Hospital, Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute |
| Q&A |
Webinar Replay
Please click the video below to watch the replay of the webinar.